SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-23-078915
Filing Date
2023-09-25
Accepted
2023-09-25 06:07:36
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea185715-424b3_ysbio.htm 424B3 113923
2 GRAPHIC image_001.jpg GRAPHIC 2717
  Complete submission text file 0001213900-23-078915.txt   118985
Mailing Address BUILDING NO. 2, 38 YONGDA ROAD DAXING BIOMEDICAL INDUSTRY PARK DAXING DISTRICT, BEIJING F4 102629
Business Address BUILDING NO. 2, 38 YONGDA ROAD DAXING BIOMEDICAL INDUSTRY PARK DAXING DISTRICT, BEIJING F4 102629 861089202086
YS Biopharma Co., Ltd. (Filer) CIK: 0001946399 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0331
Type: 424B3 | Act: 33 | File No.: 333-271221 | Film No.: 231272947
SIC: 2834 Pharmaceutical Preparations